Vol 13, No 4 (2017)
Case report
Published online: 2017-09-13
Page views 607
Article views/downloads 948
Get Citation

Connect on Social Media

Connect on Social Media

Giant-cell tumour of bone with lung metastases — case report

Katarzyna Gabalewicz1, Emilia Filipczyk- Cisarż1
DOI: 10.5603/OCP.2017.0020
Oncol Clin Pract 2017;13(4):169-171.

Abstract

Giant cell tumor of bone is usually a benign neoplasm with local malignant potential. In some cases it could be more aggressive and treatment is not always effective. The individual strategy could be beneficial and different therapeutic methods worth to use such, as bone remodeling substances, chemotherapy, radiotherapy and maybe in the future immunotherapy.

References

  1. Beebe-Dimmer JL, Cetin K, Fryzek JP, et al. The epidemiology of malignant giant cell tumors of bone: an analysis of data from the Surveillance, Epidemiology and End Results Program (1975–2004). Rare Tumors. 2009; 1(2): e52.
  2. Klenke FM, Wenger DE, Inwards CY, et al. Giant cell tumor of bone: risk factors for recurrence. Clin Orthop Relat Res. 2011; 469(2): 591–599.
  3. Singh AS, Chawla NS, Chawla SP. Giant-cell tumor of bone: treatment options and role of denosumab. Biologics. 2015; 9: 69–74.
  4. López-Pousa A, Martín Broto J, Garrido T, et al. Giant cell tumour of bone: new treatments in development. Clin Transl Oncol. 2015; 17(6): 419–430.
  5. Thomas D, Henshaw R, Skubitz K, et al. Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. The Lancet Oncology. 2010; 11(3): 275–280.
  6. Chawla S, Henshaw R, Seeger L, et al. Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study. Lancet Oncol. 2013; 14(9): 901–908.
  7. Xu SF, Adams B, Yu XC, et al. Denosumab and giant cell tumour of bone—a review and future management considerations. Curr Oncol. 2013; 20(5): 442.
  8. Skubitz KM. Giant cell tumor of bone: current treatment options. Curr Treat Options Oncol. 2014; 15(3): 507–518.
  9. Yasko A. Interferon therapy for giant cell tumor of bone. Curr Opin Orthop. 2006; 17(6): 568–572.
  10. Kaban L, Troulis M, Ebb D, et al. Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws. Journal of Oral and Maxillofacial Surgery. 2002; 60(10): 1103–1111.
  11. Ng J, Dai T. Radiation therapy and the abscopal effect: a concept comes of age. Ann Transl Med. 2016; 4(6): 118.
  12. Johnson CB, Jagsi R. The promise of the abscopal effect and the future of trials combining immunotherapy and radiation therapy. Int J Radiat Oncol Biol Phys. 2016; 95(4): 1254–1256.